Investigating better methods to preserve the health benefits of donor milk for infants
Can high pressure processing (HPP) and ultraviolet-C irradiation (UV-C) treatment preserve donor milk bioactive protein structure and function better than holder pasteurization?
This study is looking for better ways to treat donor milk so that it keeps important proteins that help preterm babies grow healthy, using methods like high pressure and UV light, to make sure the milk is safe and nutritious for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon State University NIH-funded |
| Lab location | 1 site (Corvallis, United States) |
| Project ID | NIH-10873963 on NIH RePORTER |
What this research studies
This research focuses on finding alternative methods to Holder pasteurization that can preserve the bioactive proteins in donor milk, which are crucial for the health of preterm infants. The study will explore high pressure processing (HPP) and ultraviolet-C irradiation (UV-C) as potential techniques to maintain the structure and function of these proteins while ensuring the milk is safe for consumption. By identifying the optimal processing conditions, the research aims to improve feeding practices for vulnerable infants and enhance their health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are preterm infants who require donor milk for feeding.
Not a fit: Patients who are not preterm or do not require donor milk for feeding may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved donor milk processing methods that better support the health and development of preterm infants.
How similar studies have performed: Previous research has shown that alternative processing methods like HPP and UV-C can preserve some bioactive proteins, but this study aims to systematically evaluate their effectiveness compared to traditional methods.
Where this research is happening
Corvallis, United States
- Oregon State University — Corvallis, United States (Active)
Researchers
- Principal investigator: Dallas, David Charles — Oregon State University
- Study coordinator: Dallas, David Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.